CCWM
BMY icon

Cassaday & Co Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Cassaday & Co Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520K Sell
8,579
-195
-2% -$11.4K 0.01% 218
2025
Q4 		$473K Sell
8,774
-451
-5% -$21.7K 0.01% 228
2025
Q3 		$416K Buy
9,225
+102
+1% +$4.76K 0.01% 235
2025
Q2 		$422K Sell
9,123
-46
-0.5% -$2.26K 0.01% 226
2025
Q1 		$559K Sell
9,169
-324
-3% -$18.9K 0.02% 186
2024
Q4 		$537K Sell
9,493
-1,446
-13% -$80.8K 0.01% 187
2024
Q3 		$566K Buy
10,939
+117
+1% +$5.49K 0.02% 174
2024
Q2 		$449K Sell
10,822
-2,685
-20% -$120K 0.01% 184
2024
Q1 		$732K Buy
13,507
+114
+0.9% +$5.81K 0.02% 140
2023
Q4 		$687K Sell
13,393
-6
-0% -$315 0.02% 133
2023
Q3 		$778K Sell
13,399
-1,612
-11% -$98.8K 0.03% 104
2023
Q2 		$960K Buy
15,011
+1,247
+9% +$83.6K 0.04% 97
2023
Q1 		$954K Buy
13,764
+234
+2% +$16.5K 0.04% 97
2022
Q4 		$973K Buy
+13,530
New +$1.02M 0.05% 91

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cassaday & Co Wealth Management's BMY Position: Q1 2026 in Review

Cassaday & Co Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, selling an estimated $11.4K and leaving 8,579 shares worth $520K. The position accounts for 0.01% of the portfolio, ranked #218.

Cassaday & Co Wealth Management first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $973K in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cassaday & Co Wealth Management held 8,579 shares of Bristol-Myers Squibb worth $520K as of Q1 2026.
  • Cassaday & Co Wealth Management sold 195 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.4K.
  • Bristol-Myers Squibb made up 0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #218 holding.
  • Cassaday & Co Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • Cassaday & Co Wealth Management's Bristol-Myers Squibb position peaked at $973K in Q4 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.